November 30, 2015
Cytori (CYTX) advances the cell therapy “ball” with effective topical administration in thermal burns
November 30, 2015
Flat open expected. RegMed’s pre-open, what’s viability mean?
November 25, 2015
RegMed’s close: thanks for a up/positive close day in a hit or miss sector
November 23, 2015
Lower open expected. RegMed’s pre-open, the sector has spiked higher as we await the next inversion
November 19, 2015
Higher open is expected. RegMed’s pre-open, it’s very much a whipsaw sector
November 18, 2015
RegMed’s close: seized the upside but, where is the line in the sand of support?
November 18, 2015
Lower open is expected. RegMed’s pre-open, the revolution of the carousel is not helping the sector
November 17, 2015
RegMed’s close: divergent trading is confusing investors
November 16, 2015
Regenerative Medicine Earnings Scorecard - Q3/2015
November 16, 2015
Slightly higher open expected. RegMed’s pre-open, it isn’t a total negative, nor is it a huge positive but, Monday should be an UP day!
35 companies, 1 interpreter!
Insight, foresight and recommendation
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors
© 2026 RegMed Investors (regmedinvestors.com), all rights are reserved.
RegMed Investors (RMi) or Regmedinvestors.com content is the intellectual property of Henry McCusker. Any copying, republication or redistribution of RMI’s content, including by framing or similar means, is expressly prohibited without the prior written consent of Scimitar; who also shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. For additional information on other Scimitar media services or reposting please email hwm@regmedinvestors.com.
The information included above as well as individual companies and/or securities mentioned should be construed as guidance in RMi reviews.
The facts stated and the opinions given in this publication are based on data and information considered to be reliable and have been carefully worked into my qualitative analyses and prognoses. However, no guarantee can be given as to their fairness, accuracy or completeness.
Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.